BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 7700894)

  • 1. Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging.
    Canals C; Picón M; Sanchez T; Torrico C; Amill B; Tugues D; Sierra J; Grañena A; Badell I; Brunet S
    Prog Clin Biol Res; 1994; 389():125-32. PubMed ID: 7700894
    [No Abstract]   [Full Text] [Related]  

  • 2. Autologous bone marrow transplantation after in vitro purging with monoclonal antibodies and complement in acute lymphoblastic leukemia.
    Perez-Oteyza J; Larana JG; Brieva J; Roldan E; Odriozola J; Maldonado M; Otheo E; Munoz A; Bootello A; Navarro JL
    Prog Clin Biol Res; 1992; 377():163-8. PubMed ID: 1438412
    [No Abstract]   [Full Text] [Related]  

  • 3. [Autologous BMT for B-lineage adult ALL patients using ex vivo purging with monoclonal antibodies].
    Mizuta S; Kawano A
    Rinsho Ketsueki; 1997 May; 38(5):422-5. PubMed ID: 9194387
    [No Abstract]   [Full Text] [Related]  

  • 4. Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement.
    Grañena A; Castellsagué X; Badell I; Ferra C; Ortega J; Brunet S; Puntí C; Sureda A; Picón M; Valls A; Rutllant M; García J
    Bone Marrow Transplant; 1999 Sep; 24(6):621-7. PubMed ID: 10490727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts.
    Vervoordeldonk SF; Merle PA; Steenbergen EJ; van Leeuwen EF; von dem Borne AE; Slaper-Cortenbach IC
    Prog Clin Biol Res; 1994; 389():601-9. PubMed ID: 7700926
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunomagnetic purging in autologous bone marrow transplantation: experience in fourteen patients.
    Canals C; Puntí C; Picón M; Amill B; Tugues D; Sanchez T; Badell I; Pardo N; Ortega J; Vivancos P
    Prog Clin Biol Res; 1992; 377():289-96. PubMed ID: 1438427
    [No Abstract]   [Full Text] [Related]  

  • 7. [Monoclonal antibody and purging].
    Ueda R; Morishima Y
    Gan No Rinsho; 1989 May; Spec No():294-302. PubMed ID: 2601016
    [No Abstract]   [Full Text] [Related]  

  • 8. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
    Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
    Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acute lymphoblastic leukemia.
    Hoelzer D
    Semin Hematol; 1994 Jan; 31(1):1-15. PubMed ID: 8122133
    [No Abstract]   [Full Text] [Related]  

  • 10. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
    Parsons SK; Castellino SM; Lehmann LE; Eickhoff CE; Tarbell NJ; Sallan SE; Weinstein HJ; Billett AL
    Bone Marrow Transplant; 1996 May; 17(5):763-8. PubMed ID: 8733695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute leukemia: autologous transplantation of bone marrow cells grown in long-term culture containing low molecular weight natural tumour suppressor].
    Yang K; Teng AP; Pei ZT
    Zhonghua Yi Xue Za Zhi; 1994 May; 74(5):287-9, 325-6. PubMed ID: 7953919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow purging with immunotoxins for treatment of T cell acute lymphoblastic leukemia (T-ALL).
    Vallera DA; Uckun FM
    Prog Clin Biol Res; 1990; 333():191-204; discussion 205. PubMed ID: 2308981
    [No Abstract]   [Full Text] [Related]  

  • 13. Autologous bone-marrow transplantation for Burkitt's lymphoma: marrow purging with anti-Y 29/55 monoclonal antibody and complement.
    Baumgartner C; Delaleu B; Imbach P; Lüthy A; Odavic R; Brun del Re G; Bucher U; Forster HK; Hirt A; Wagner HP
    IARC Sci Publ; 1985; (60):435-40. PubMed ID: 3905594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of minimal residual disease in patients with childhood common acute lymphoblastic leukemia after autologous bone marrow transplantation with ex vivo purging and systemic IL-2 infusion: unsuccessful prediction of subsequent relapse.
    Kiyoi H; Kojima S; Kato K; Matsuyama T; Kodera Y; Ohno R; Naoe T
    Bone Marrow Transplant; 1995 Sep; 16(3):437-42. PubMed ID: 8535317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody 55 (CD10) and complement used for purging autologous bone marrow in common acute lymphoblastic leukemia.
    Bai Y; Piao XH; Luo QL; Mao BZ
    Chin Med J (Engl); 1990 May; 103(5):385-90. PubMed ID: 2118055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM-CSF administration enhances granulocytic recovery in purged autologous bone marrow transplantation for acute lymphoblastic leukemia.
    Sureda A; Canals C; Badell I; Nomdedeu J; Llácer M; Brunet S; Sierra J; Grañena A; Cubells J; Domingo-Albós A
    Prog Clin Biol Res; 1992; 377():315-20. PubMed ID: 1438428
    [No Abstract]   [Full Text] [Related]  

  • 17. Autologous bone marrow transplantation for acute myeloid leukemia using monoclonal antibody-purged bone marrow.
    Ball ED; Mills L; Hurd D; McMillan R; Gingrich R
    Prog Clin Biol Res; 1992; 377():97-110; discussion 111. PubMed ID: 1438450
    [No Abstract]   [Full Text] [Related]  

  • 18. [Autologous bone marrow transplantation in acute lymphoblastic leukemia].
    Tura S; Visani G; Gamberi B
    Haematologica; 1991 Jun; 76 Suppl 3():327-36. PubMed ID: 1684347
    [No Abstract]   [Full Text] [Related]  

  • 19. Autologous bone marrow transplantation for leukemia.
    Stuart RK
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Shin HJ; Chung JS; Cho GJ
    Bone Marrow Transplant; 2005 Nov; 36(10):917-8. PubMed ID: 16113662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.